| Document |
Document Title |
|
WO/2020/248943A1 |
The present application provides a nitrogen-containing compound, an electronic component and an electronic device, and belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown in ...
|
|
WO/2020/244323A1 |
Disclosed are a preparation method for a cis-p-mentha-1,8-secondary amine compound and a herbicidal application thereof. The method comprises: using a cis-p-mentha-1,8-di-schiff base compound as a raw material, putting reducing agents in...
|
|
WO/2020/243048A1 |
A process for producing products that comprise linear triethylenetetramine, wherein the process comprises forming a reaction mixture comprising ethylene dichloride and piperazine, wherein the weight ratio of piperazine to ethylene dichlo...
|
|
WO/2020/237835A1 |
Disclosed are a spirobifluorene organic light-emitting compound and an organic light-emitting device. The spirobifluorene organic light-emitting compound has a structural formula as shown in formula I. Such a compound can be used as an o...
|
|
WO/2020/185054A9 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/232027A1 |
Presented herein are color stabilized diamine compositions comprising a diamine and a sulfur compound. The diamine can have an aromatic moiety. The sulfur compound includes methanethiol, ethanethiol, 1-propanethiol, 2-propanethiol, 2-pro...
|
|
WO/2020/226521A1 |
The present invention falls within the area of the synthesis of ionic liquids, namely it concerns a process of synthesis of the ionic liquid tetraoctylammonium dioctyl-diglycolamate (IL-4) with a high degree of purity and its use in an e...
|
|
WO/2020/224483A1 |
A method for preparing a highly dispersed ultrafine bimetallic shaped catalyst is provided. Said catalyst is obtainable by a method of solid-state seeded-growth strategy. Said method comprises: mixing an aromatic compound containing at l...
|
|
WO/2020/220510A1 |
A pyrene blue fluorescent dopant, and an organic electroluminescent device comprising same. The structural formula of the compound is shown in formula (I). The compound can be applied as an organic electroluminescent material, has the li...
|
|
WO/2020/220942A1 |
A compound, an organic electroluminescent device containing the compound, and an application thereof. The compound has a structure shown in (I).
|
|
WO/2020/222011A1 |
The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
|
|
WO/2020/217001A1 |
A process for producing tetraethylammonium bromide, and also a process for producing tetraethylammonium tetrafluoroborate from tetraethylammonium bromide, are obtained. These processes make it possible to obtain tetraethylammonium tetraf...
|
|
WO/2020/215895A1 |
The present invention relates to the technical field of medicine, and relates to derivatives represented by formula 1 and formula 2 in which a carboxylic acid group is introduced into the structure of ginkgolide B by means of a hydroxyl ...
|
|
WO/2020/214841A1 |
Salts of hexylamine, for example, hexylamine succinate and tri-hexylamine citrate and their method of production are described. The disclosure also relates to compositions comprises hexyalmine and the use of hexylamine for for reducing a...
|
|
WO/2020/212890A1 |
Disclosed herein is a method for synthesizing levomethadone hydrochloride including producing (R)-2-(dimethylamino)propan-1-ol by reducing Ν,Ν-dimethyl-D-alanine using borax, forming (R)-1-chloro-N,N-dimethylpropane-2-amine hydrochlori...
|
|
WO/2020/214692A1 |
Tertiary amine and quaternary ammonium compounds of Formula I and/or Formula II are provided. The present technology also provides compositions that include one or more of the compounds that may be useful for electronics processing (e.g....
|
|
WO/2020/206754A1 |
A solvent-free preparation method for an oxidative coupling high-temperature antioxidant, the specific preparation steps being as follows: adding N-phenyl-α-methylnaphthylamine or alkylated N-phenyl-α-methylnaphthylamine and an alkylat...
|
|
WO/2020/207874A1 |
The invention relates to a catalyst system suitable for hydrogenating aromatic nitro compounds (I) to form the corresponding aromatic amines (II), the catalyst system containing, as essential constituents: a component A selected from the...
|
|
WO/2020/207129A1 |
Disclosed is an ammonium salt with a structural formula represented by formula (I). A synthesis method thereof comprises using 8 mol% zinc chloride as a catalyst, 5 mmol of 1-phenyl-1,3-butanedione, 1.2 g of benzylamine, and 40 mL of chl...
|
|
WO/2020/202131A1 |
A method for obtaining a salt with a general formula: RxNI, wherein: RxN is an organic cation (RxN+), R represents substituents (R-) independently selected from a group consisting of organic substituents: R1-, R2-, R3- and hydrogen (H-),...
|
|
WO/2020/202179A1 |
The present invention provides a polysaccharide supported fluorinating agents which can be used in fluorination reactions. The invention particularly describes a new bacterial cellulose supported tetra-n-butyl ammonium fluoride complex [...
|
|
WO/2020/191503A1 |
Methods and uses of bromantane and derivatives of the Formula (Ia) or (Ib) for treating fibrotic diseases are taught, and in particular, chronic lung disease, including idiopathic pulmonary fibrosis; non-alcoholic fatty liver disease, an...
|
|
WO/2020/196854A1 |
The present invention addresses the problem of providing: a composition for forming a resist underlayer film excellent in terms of etching resistance, heat resistance, flatness, and bending resistance; a resist underlayer film; a method ...
|
|
WO/2020/193419A1 |
The present invention relates to novel compounds, pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of potassium channels.
|
|
WO/2020/190493A1 |
Compositions and methods are provided for treating a pavement such as by microsurfacing or slurry sealing. The compositions contain iron chelants that are effective in reducing discoloration of the pavement surface.
|
|
WO/2020/189227A1 |
A method for producing xylylenediamine, which comprises the following steps: (1) a first hydrogenation step wherein a mixed liquid, which is composed of dicyanobenzene and a solvent containing liquid ammonia, is hydrogenated by means of ...
|
|
WO/2020/185096A1 |
The present invention is directed to a composition for use in recovering an alcohol from an aqueous solution the composition comprising: a) a recovery solution comprising at least one tertiary amine containing compound and at least one e...
|
|
WO/2020/185738A1 |
The present application discloses heteroaromatic and heterobicyclic aromatic derivative compounds and compositions, and methods for treating ferroptosis-related disorders and diseases in patients using the compounds and compositions as d...
|
|
WO/2020/178219A1 |
A process to produce polyalkylene-polyamines wherein an alkylene-diamine, a hydroxyalkylene-amine and hydrogen are reacted in presence of an heterogenous catalyst comprising copper.
|
|
WO/2020/179579A1 |
A compound having a (1) perovskite crystal structure such that the full width at half maximum of a peak in a plane Miller index (001) of the X-ray diffraction pattern thereof is at least 0.10 and less than 0.60, and comprising a monovale...
|
|
WO/2020/180825A1 |
This is invention is related to processes for synthesis of levoamphetamine derivatives and novel intermediates thereby, and processes for using the same.
|
|
WO/2020/181143A1 |
The invention relates generally to the following novel fendiline derivatives, and the preparation and use thereof: Formula I (I) and Formula II (II)
|
|
WO/2020/180019A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/178085A1 |
The present invention relates to a process for preparing alkanolamines and ethyleneamines in the liquid phase, by reacting ethylene glycol and/or monoethanolamine with ammonia in the presence of an amination catalyst which is obtained by...
|
|
WO/2020/179489A1 |
This compound has a perovskite type crystal structure including, as constituting components, A which is a monovalent cation, B which is a metal ion, and X which is a halide ion, wherein the unit lattice volume thereof is 0.2000-0.2150 nm...
|
|
WO/2020/177778A1 |
The present invention discloses a 1-pyridylpyrazole amide compound represented by formula (I), the preparation method and application thereof, and each substituent in the formula has the definition given by the description. The compound ...
|
|
WO/2020/175671A1 |
A polymer which has a constituent component represented by formula (I); a method for producing this polymer; a diamine compound which is useful as a starting material for this polymer; a gas separation membrane which has a gas separation...
|
|
WO/2020/174030A1 |
Acatalyst composition comprising at least one compound with a general formula (I) wherein A is N-R3, R3 is C1-C8 linear or branched, x = 0-6, n and m are each independently 1 to 6, R1 and R2 are each independently C2 -C8 alkyl, and R4 an...
|
|
WO/2020/175309A1 |
This catalyst for amide compound hydrogenation is capable of carrying out a reduction reaction that converts an amide compound into an amine compound, and is characterized by including rhodium and molybdenum being supported on hydroxyapa...
|
|
WO/2020/175380A1 |
Provided are a novel amine composition and amine compound. Provided are a production method thereof, as well as an epoxy resin curing agent, an epoxy resin composition, a cured product, a urethane prepolymer curing agent, a polyurethane ...
|
|
WO/2020/174346A1 |
The present invention relates to a novel tetraarylborate compound, a catalyst composition comprising same, and a method for preparing ethylene homopolymers or copolymers of ethylene and α-olefins by using same. In detail, the tetraarylb...
|
|
WO/2020/170080A1 |
A hydrofluoroolefin compound is represented by the following general formula (I): where RF1 is a hydrogen atom or CH3, and (iii) RF1 is a linear or branched perfluorinated alkyl group having 1 to 10 carbon atoms and optionally including ...
|
|
WO/2020/170971A1 |
The first objective of the present invention is to provide a composition which enables the achievement of a cured product that has excellent antibacterial properties. The second objective of the present invention is to provide a cured pr...
|
|
WO/2020/169060A1 |
Disclosed is an organic compound having a spirobifluorene structure containing a diarylamine substituent group, having a structure as shown in formula (1). The compound has a non-planar spatial structure, a higher glass transition temper...
|
|
WO/2020/171210A1 |
The phytol contained in watermelon sprouts is known to have a cancer cell growth inhibiting effect. The problem, however, is the amount ingested to inhibit cancer cell growth is large. A cancer cell growth inhibiting composition having...
|
|
WO/2020/163966A1 |
The use of pharmaceutically active compounds for treating chronic lung diseases including idiopathic pulmonary fibrosis is disclosed. The compounds include NMDA receptor antagonists, glutamate 2b receptor antagonists and sigma receptor a...
|
|
WO/2020/166677A1 |
Provided is, inter alia, a processing solution for semiconductor wafers for use in a semiconductor formation process. Provided is, inter alia, a processing solution that contains (A) hypochlorite ions and (B) an alkylammonium salt repres...
|
|
WO/2020/166984A1 |
The present invention pertains to: CPNA prepared by reacting 4-CA and F-NO2 with a polar aprotic solvent having a boiling point higher than the reaction temperature, and CPDA prepared by reacting 4-CA and F-NO2 with a sulfur compound hav...
|
|
WO/2020/165338A1 |
The invention pertains to a process for manufacturing ethyleneamine compounds selected from the group of ethyleneamines and hydroxyethylethyleneamines wherein the process comprises two reaction sequences, the first reaction sequence comp...
|
|
WO/2020/167948A1 |
Provided herein are compositions and methods for improving outcome in stem cell transplantation. In particular, provided herein are compositions and methods for improving efficacy and reducing graft versus host disease in allogenic cell ...
|
